Menu
1. Léucemie Lymphoide Chronique (LLC) et lymphomes de bas grade: J’ai comme un blanc
2. Pas de conflits d'intérêt
3. Plan
4. WHO Classification
5. WHO Classification
6. WHO Classification
7. The origin of B-cell lymphomas
8. The origin of B-cell lymphomas
9. B-cell lymphomas: incidence
10. Indolent lymphomas: common features
11. Indolent lymphomas: common features
12. PET-CT in indolent lymphomas
13. Indolent lymphomas: Clinical presentation
14. Plan
15. Chronic Lymphocytic Leukemia (CLL)
16. CLL
17. CLL diagnosis: QUICK AND SIMPLE!!
18. CLL diagnosis: QUICK AND SIMPLE!!
19. Chronic Lymphocytic Leukemia (CLL)
20. CLL: Pre-treatment considerations
21. LLC: Does my patient have 1 of these?
22. CLL: Clinical classification
23. CLL: Pre-treatment considerations
24. CLL: Pre-treatment considerations
25. CLL: Treatment Options
26. CLL: Chemotherapy ?
27. CLL: First line treatment
28. CLL: Novel agents target specific pathways
29. First-line Ibrutinib ?
30. CLL: Relapse: what to choose?
31. Plan
32. Follicular Lymphoma
33. CLL
34. Follicular Lymphoma
35. Lymphoma Staging: Ann Arbor
36. Follicular lymphoma: Histologic grade
37. Prognostic score: FLIPI 1
38. Follicular lymphoma: Do I start treatment ?
39. Follicular lymphoma: First line treatment
40. Follicular Lymphoma: Relapse
41. Potential histologic transformation into AGGRESSIVE LYMPHOMAS
42. SUMMARY:
43. Plan
44. Indolent lymphomas: Take home messages
45. Important messages in lymphomas
46. Service d'hématologie
47. Merci beaucoup pour votre attention
LLC et Lymphomes bas grade, Dre Carmen de Ramon Ortiz, 30.03.21
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All